Labcorp Holdings Inc.(LH)Earnings, Financials & Key Ratios

LH•NYSE

$256.93

$21.14B mkt cap·24.6× P/E·Price updated May 6, 2026

SectorHealthcare IndustryMedical Equipment Sub-IndustryDiagnostics and Lab Testing Services

AboutLabcorp Holdings, Inc. provides laboratory services to help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.Show more

Revenue$13.95B+7.2%
EBITDA$2.2B+27.0%
Net Income$877M+17.5%
EPS (Diluted)10.46+18.3%
Gross Margin26.75%-4.0%
EBITDA Margin15.75%+18.4%
Operating Margin10.87%+30.1%
Net Margin6.28%+9.6%
ROE10.5%+12.2%
ROIC7.81%+29.9%
Debt/Equity0.83-7.5%
Interest Coverage5.94+6.0%

Analysis→Technical→

LH Key Insights

Labcorp Holdings Inc. (LH) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income

✗Weaknesses

✗Profits declining 10.8% over 5 years

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

LH Price & Volume

Labcorp Holdings Inc. (LH) stock price & volume — 10-year historical chart

Loading chart...

LH Growth Metrics

Labcorp Holdings Inc. (LH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years4.86%

5 Years-0.04%

3 Years5.55%

TTM7.34%

Profit CAGR

10 Years7.21%

5 Years-10.85%

3 Years-11.84%

TTM28.83%

EPS CAGR

10 Years9.2%

5 Years-8.01%

3 Years-9.17%

TTM30.22%

Return on Capital

10 Years10.22%

5 Years9.63%

3 Years7.42%

Last Year9.9%

LH Recent Earnings

Labcorp Holdings Inc. (LH) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (83%)●Beat Revenue 9/12 qtrs (75%)

Q1 2026Latest

Feb 17, 2026

EPS

$4.07

Est $3.95

+3.0%

Revenue

$3.5B

Est $3.6B

-1.2%

Q4 2025

Oct 28, 2025

EPS

$4.18

Est $4.13

+1.2%

Revenue

$3.6B

Est $3.6B

+0.2%

Q3 2025

Jul 24, 2025

EPS

$4.35

Est $4.17

+4.3%

Revenue

$3.5B

Est $3.5B

+1.2%

Q2 2025

Apr 29, 2025

EPS

$3.84

Est $3.74

+2.7%

Revenue

$3.3B

Est $3.4B

-1.6%

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 17, 2026	$4.07vs $3.95+3.0%	$3.5Bvs $3.6B-1.2%
Q4 2025	Oct 28, 2025	$4.18vs $4.13+1.2%	$3.6Bvs $3.6B+0.2%
Q3 2025	Jul 24, 2025	$4.35vs $4.17+4.3%	$3.5Bvs $3.5B+1.2%
Q2 2025	Apr 29, 2025	$3.84vs $3.74+2.7%	$3.3Bvs $3.4B-1.6%

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
DGXQuest Diagnostics IncorporatedDirect Competitor	20.93B	189.13	21.61	11.78%	9.08%	13.8%	0.95
SLNOSoleno Therapeutics, Inc.Direct Competitor	2.76B	52.94	135.74		10.97%	5.9%	0.01
EXASExact Sciences CorporationDirect Competitor	20.02B	104.91	-95.37	17.69%	-6.4%	-8.66%	1.05
BIOBio-Rad Laboratories, Inc.Direct Competitor	6.99B	259.02	9.29	0.65%	6.52%	2.4%	0.21
NTRANatera, Inc.Direct Competitor	29.58B	215.09	-140.58	56.75%	-14.61%	-24.69%	0.16
IQVIQVIA Holdings Inc.Product Competitor	29.95B	176.47	22.51	5.87%	8.33%	22.11%	2.44
CRLCharles River Laboratories International, Inc.Product Competitor	8.97B	181.73	-62.45	-0.85%	-3.59%	-4.34%	0.95
MEDPMedpace Holdings, Inc.Product Competitor	12.19B	426.79	27.93	19.97%	17.19%	120.89%	0.55

Compare LH vs Peers

Labcorp Holdings Inc. (LH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs DGX

Most directly comparable listed peer for LH.

Scale Benchmark

vs TMO

Larger-name benchmark to compare LH against a more recognizable public peer.

Peer Set

Compare Top 5

vs DGX, SLNO, EXAS, BIO

LH Income Statement

Labcorp Holdings Inc. (LH) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Sales/Revenue	10.44B	11.33B	11.55B	13.98B	13.14B	11.86B	12.16B	13.01B	13.95B	14.14B
Revenue Growth %	8.29%	8.54%	1.95%	20.98%	-6.03%	-9.68%	2.51%	6.97%	7.25%	7.34%
Cost of Goods Sold	6.98B	8.16B	8.3B	9.03B	8.14B	8.15B	8.8B	9.38B	10.22B	10.21B
COGS % of Revenue	66.82%	71.97%	71.85%	64.57%	61.99%	68.74%	72.33%	72.14%	73.25%	-
Gross Profit	3.46B▲ 0%	3.18B▼ 8.3%	3.25B▲ 2.4%	4.95B▲ 52.3%	4.99B▲ 0.8%	3.71B▼ 25.7%	3.36B▼ 9.3%	3.62B▲ 7.7%	3.73B▲ 3.0%	3.93B▲ 0%
Gross Margin %	33.18%	28.03%	28.15%	35.43%	38.01%	31.26%	27.67%	27.86%	26.75%	27.79%
Gross Profit Growth %	8.91%	-8.3%	2.4%	52.28%	0.8%	-25.71%	-9.28%	7.71%	2.98%	-
Operating Expenses	2.03B	1.8B	1.87B	2.51B	1.94B	2.27B	2.64B	2.54B	2.22B	2.37B
OpEx % of Revenue	19.43%	15.91%	16.16%	17.94%	14.8%	19.15%	21.7%	19.51%	15.89%	-
Selling, General & Admin	1.81B	1.57B	1.62B	1.73B	1.69B	2B	2.02B	2.23B	2.22B	2.22B
SG&A % of Revenue	17.36%	13.86%	14.06%	12.37%	12.87%	16.83%	16.62%	17.14%	15.89%	-
Research & Development	0	0	0	0	0	0	2M	0	0	0
R&D % of Revenue	-	-	-	-	-	-	0.02%	-	-	-
Other Operating Expenses	-7.6M	167.7M	243.2M	778.1M	253.5M	275.8M	615.9M	307.7M	0	2M
Operating Income	1.36B▲ 0%	1.33B▼ 2.8%	1.33B▲ 0.3%	2.45B▲ 83.8%	3.05B▲ 24.7%	1.44B▼ 52.9%	725.6M▼ 49.5%	1.09B▲ 49.8%	1.52B▲ 39.5%	1.56B▲ 0%
Operating Margin %	13.07%	11.7%	11.51%	17.49%	23.21%	12.11%	5.97%	8.35%	10.87%	11.03%
Operating Income Growth %	3.95%	-2.82%	0.34%	83.84%	24.67%	-52.88%	-49.49%	49.77%	39.52%	-
EBITDA	1.9B	1.88B	2.1B	3.27B	3.63B	1.97B	1.3B	1.73B	2.2B	2.25B
EBITDA Margin %	18.17%	16.57%	18.19%	23.4%	27.6%	16.64%	10.71%	13.3%	15.75%	15.89%
EBITDA Growth %	5.24%	-1.03%	11.91%	55.62%	10.86%	-45.56%	-33.99%	32.8%	27%	28.66%
D&A (Non-Cash Add-back)	533.2M	552.1M	771.3M	825M	577M	537.2M	577.3M	643.5M	681.1M	687.6M
EBIT	1.31B	1.51B	1.35B	2.43B	3.1B	1.42B	768.5M	1.17B	1.33B	1.39B
Net Interest Income	-235.1M	-244.2M	-240.7M	-207.4M	-211.8M	-179.8M	-199.6M	-208.3M	-208.9M	-205.8M
Interest Income	0	0	0	0	0	0	0	0	15.2M	17.4M
Interest Expense	235.1M	244.2M	240.7M	207.4M	211.8M	179.8M	199.6M	208.3M	224.1M	223.2M
Other Income/Expense	-227.7M	-57.4M	-225.3M	-226.3M	-161M	-199.1M	-156.7M	-127.2M	-408.7M	-408.3M
Pretax Income	1.13B▲ 0%	1.27B▲ 11.8%	1.1B▼ 12.9%	2.22B▲ 100.8%	2.89B▲ 30.1%	1.24B▼ 57.1%	568.9M▼ 54.0%	959.5M▲ 68.7%	1.11B▲ 15.4%	1.15B▲ 0%
Pretax Margin %	10.87%	11.19%	9.56%	15.88%	21.98%	10.43%	4.68%	7.38%	7.94%	8.14%
Income Tax	-139.1M	384.4M	280M	662.1M	690M	233.9M	188.5M	212.4M	229.8M	209.3M
Effective Tax Rate %	-12.26%	30.31%	25.34%	29.84%	23.9%	18.9%	33.13%	22.14%	20.75%	18.17%
Net Income	1.27B▲ 0%	883.7M▼ 30.3%	823.8M▼ 6.8%	1.56B▲ 88.9%	2.38B▲ 52.8%	1.28B▼ 46.2%	418M▼ 67.3%	746M▲ 78.5%	876.5M▲ 17.5%	941.5M▲ 0%
Net Margin %	12.15%	7.8%	7.13%	11.13%	18.1%	10.78%	3.44%	5.73%	6.28%	6.66%
Net Income Growth %	73.23%	-30.32%	-6.78%	88.89%	52.77%	-46.2%	-67.32%	78.47%	17.49%	28.83%
Net Income (Continuing)	1.23B	883.9M	824.9M	1.56B	2.2B	1B	380.4M	747.1M	877.7M	942.5M
Discontinued Operations	0	0	0	0	181.9M	277.1M	38.8M	0	0	0
Minority Interest	20.8M	19.1M	20.1M	20.7M	20.6M	18.9M	15.5M	14.3M	16.9M	16.9M
EPS (Diluted)	12.21▲ 0%	8.61▼ 29.5%	8.36▼ 2.9%	15.88▲ 90.0%	24.38▲ 53.5%	13.96▼ 42.7%	4.77▼ 65.8%	8.84▲ 85.3%	10.46▲ 18.3%	11.36▲ 0%
EPS Growth %	73.93%	-29.48%	-2.9%	89.95%	53.53%	-42.74%	-65.83%	85.32%	18.33%	30.22%
EPS (Basic)	12.39	8.71	8.41	15.99	24.58	14.04	4.80	8.89	10.54	-
Diluted Shares Outstanding	103.9M	102.6M	98.6M	98M	97.5M	91.6M	87.6M	84.4M	83.8M	82.9M
Basic Shares Outstanding	102.4M	101.4M	97.9M	97.3M	96.7M	91.1M	87.1M	83.9M	83.2M	82.3M
Dividend Payout Ratio	-	-	-	-	-	15.26%	60.77%	32.59%	27.46%	-

LH Balance Sheet

Labcorp Holdings Inc. (LH) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Total Current Assets	2.68B	2.84B	2.98B	5.13B	5.33B	4.63B	3.77B	4.81B	4.02B	4.56B
Cash & Short-Term Investments	316.7M	426.8M	337.5M	1.32B	1.47B	320.6M	536.8M	1.52B	532.3M	981.1M
Cash Only	316.6M	426.8M	337.5M	1.32B	1.47B	320.6M	536.8M	1.52B	532.3M	981.1M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	1.85B	1.86B	2.03B	3.02B	2.98B	2B	2.1B	2.1B	2.26B	2.29B
Days Sales Outstanding	64.58	59.98	63.98	78.77	82.76	61.45	62.99	58.84	59.14	58.65
Inventory	227.6M	237.3M	244.7M	423.2M	401.4M	470.6M	474.6M	493.2M	534.7M	497.7M
Days Inventory Outstanding	11.91	10.62	10.76	17.11	17.99	21.06	19.69	19.18	19.1	18.42
Other Current Assets	88.9M	0	0	0	0	1.84B	655.3M	697.6M	692.8M	791.4M
Total Non-Current Assets	13.89B	13.35B	15.04B	14.95B	15.05B	15.53B	12.96B	13.57B	14.37B	14.53B
Property, Plant & Equipment	1.75B	1.78B	2.61B	2.73B	2.82B	2.79B	2.91B	3.05B	3.08B	3.07B
Fixed Asset Turnover	5.97x	6.35x	4.42x	5.12x	4.67x	4.25x	4.18x	4.27x	4.53x	4.57x
Goodwill	7.53B	7.36B	7.87B	7.75B	7.96B	6.12B	6.14B	6.37B	6.79B	6.96B
Intangible Assets	4.34B	3.91B	4.03B	3.96B	3.74B	3.12B	3.34B	3.49B	3.6B	3.64B
Long-Term Investments	58.4M	60.5M	84.9M	73.5M	60.9M	65.7M	26.9M	16.3M	153.9M	629.1M
Other Non-Current Assets	605.3M	276M	435.4M	410M	462.6M	3.42B	536.5M	652.2M	751.3M	2.76B
Total Assets	16.57B▲ 0%	16.19B▼ 2.3%	18.02B▲ 11.3%	20.07B▲ 11.4%	20.39B▲ 1.6%	20.16B▼ 1.1%	16.73B▼ 17.0%	18.38B▲ 9.9%	18.39B▲ 0.1%	19.09B▲ 0%
Asset Turnover	0.63x	0.70x	0.64x	0.70x	0.64x	0.59x	0.73x	0.71x	0.76x	0.77x
Asset Growth %	16.29%	-2.31%	11.34%	11.38%	1.56%	-1.13%	-17.02%	9.89%	0.07%	14.68%
Total Current Liabilities	2.19B	1.88B	2.66B	3.08B	2.78B	3.08B	3.23B	3.33B	2.82B	2.64B
Accounts Payable	573.9M	634.6M	632.3M	638.9M	621.3M	852.2M	827.5M	875.8M	840.8M	695.7M
Days Payables Outstanding	30.02	28.4	27.8	25.84	27.85	38.14	34.34	34.06	30.03	26.78
Short-Term Debt	409.2M	10M	415.2M	376.7M	1.5M	301.3M	999.8M	1B	695.8M	688.2M
Deferred Revenue (Current)	380.8M	356.4M	451M	506.5M	558.5M	310.6M	421.7M	392.2M	439.1M	1.63B
Other Current Liabilities	432.8M	427.6M	474.6M	623.2M	735.5M	1.1B	431.4M	495.4M	847.8M	851.9M
Current Ratio	1.23x	1.51x	1.12x	1.66x	1.92x	1.50x	1.17x	1.44x	1.42x	1.42x
Quick Ratio	1.12x	1.38x	1.03x	1.53x	1.77x	1.35x	1.02x	1.30x	1.23x	1.23x
Cash Conversion Cycle	46.47	42.2	46.94	70.05	72.9	44.37	48.34	43.96	48.21	50.29
Total Non-Current Liabilities	7.66B	7.32B	7.8B	7.54B	7.31B	6.96B	5.61B	6.98B	6.93B	7.7B
Long-Term Debt	6.29B	5.99B	5.79B	5.42B	5.42B	5.04B	4.05B	5.33B	5.77B	6.55B
Capital Lease Obligations	57.8M	51M	687.7M	762M	727.1M	736.5M	727.5M	750.6M	745.6M	2.28B
Deferred Tax Liabilities	875.5M	940M	942.8M	828.5M	762.9M	543.4M	417.9M	383.1M	454.5M	1.71B
Other Non-Current Liabilities	442.3M	334M	383.2M	526.4M	402M	642.4M	409.3M	517.4M	-34.8M	1.25B
Total Liabilities	9.85B	9.19B	10.46B	10.61B	10.09B	10.04B	8.83B	10.31B	9.76B	10.34B
Total Debt	6.76B	6.06B	7.11B	6.76B	6.34B	6.25B	5.95B	7.27B	7.2B	7.24B
Net Debt	6.45B	5.63B	6.77B	5.44B	4.87B	5.93B	5.42B	5.75B	6.67B	6.26B
Debt / Equity	0.99x	0.87x	0.94x	0.71x	0.62x	0.62x	0.75x	0.90x	0.83x	0.83x
Debt / EBITDA	3.56x	3.23x	3.38x	2.07x	1.75x	3.16x	4.57x	4.20x	3.28x	3.22x
Net Debt / EBITDA	3.40x	3.00x	3.22x	1.66x	1.34x	3.00x	4.16x	3.33x	3.04x	3.04x
Interest Coverage	5.58x	6.19x	5.59x	11.70x	14.63x	7.88x	3.85x	5.61x	5.94x	6.22x
Total Equity	6.82B▲ 0%	6.99B▲ 2.4%	7.59B▲ 8.5%	9.46B▲ 24.6%	10.29B▲ 8.8%	10.12B▼ 1.7%	7.89B▼ 22.0%	8.07B▲ 2.2%	8.64B▲ 7.1%	8.75B▲ 0%
Equity Growth %	23.62%	2.43%	8.53%	24.65%	8.85%	-1.73%	-22%	2.23%	7.07%	24.45%
Book Value per Share	65.69	68.13	76.95	96.50	105.58	110.43	90.07	95.57	103.06	105.49
Total Shareholders' Equity	6.8B	6.97B	7.57B	9.44B	10.27B	10.1B	7.88B	8.05B	8.62B	8.73B
Common Stock	12M	11.7M	9M	9M	8.5M	8.1M	7.7M	7.6M	7.5M	7.4M
Retained Earnings	6.22B	7.08B	7.9B	9.48B	10.46B	10.58B	7.89B	8.3B	8.64B	8.78B
Treasury Stock	-1.06B	-1.11B	0	0	0	0	0	0	0	0
Accumulated OCI	-335.7M	-463.1M	-372.4M	-161.9M	-192M	-493.2M	-59.3M	-261.6M	-27.6M	-63.2M
Minority Interest	20.8M	19.1M	20.1M	20.7M	20.6M	18.9M	15.5M	14.3M	16.9M	16.9M

LH Cash Flow Statement

Labcorp Holdings Inc. (LH) cash flow — operating, investing & free cash flow history

Line item	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	Dec'25	TTM
Cash from Operations	1.46B	1.31B	1.44B	2.14B	3.11B	1.96B	1.33B	1.59B	1.64B	1.64B
Operating CF Margin %	13.98%	11.52%	12.5%	15.28%	23.67%	16.49%	10.92%	12.19%	11.76%	-
Operating CF Growth %	24.11%	-10.55%	10.67%	47.8%	45.63%	-37.1%	-32.12%	19.44%	3.45%	964.4%
Net Income	1.27B	883.9M	824.9M	1.56B	2.38B	1B	379.2M	746M	877.7M	941.5M
Depreciation & Amortization	533.2M	552.1M	577.2M	624.7M	577M	537.2M	577.3M	643.5M	681.1M	687.6M
Stock-Based Compensation	109.7M	91.6M	107M	111.7M	132.9M	116.8M	128.7M	116.7M	125.8M	124.7M
Deferred Taxes	-542.2M	22.2M	29.2M	-47M	-37.3M	26.3M	-78.1M	-20.1M	97.6M	105.7M
Other Non-Cash Items	25.8M	-174.1M	200.8M	745.8M	321.2M	875.5M	682.5M	253.8M	384.4M	648.6M
Working Capital Changes	58.9M	-70.3M	-294.4M	-856.9M	-263.7M	-603.4M	-361.9M	-154.1M	-526.1M	-434.3M
Change in Receivables	-2.1M	50.2M	-64.1M	-955.9M	222M	15.9M	-75.3M	98.5M	-122.2M	-149.4M
Change in Inventory	-16.4M	-18.9M	-21.9M	-196.6M	2.8M	-45.5M	-700K	-14.6M	-30.2M	-3.2M
Change in Payables	85.6M	43.3M	-12.8M	-5.3M	-10.2M	307.1M	-42.4M	210.3M	-52.8M	-43.9M
Cash from Investing	-2.23B	206.7M	-1.28B	-643.2M	-884.6M	-1.65B	-1.17B	-1.37B	-1.19B	-1.18B
Capital Expenditures	-315.4M	-379.8M	-400.2M	-381.7M	-460.4M	-481.9M	-453.6M	-489.9M	-434.5M	-429.5M
CapEx % of Revenue	3.02%	3.35%	3.46%	2.73%	3.5%	4.06%	3.73%	3.77%	3.11%	-
Acquisitions	-1.92B	-136.4M	-876M	-267.6M	-496.9M	-1.16B	-671.5M	-823.9M	-582M	-730.7M
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	5.5M	324.8M	7.7M	42.1M	87.3M	1.4M	-24.1M	2M	8M	15.3M
Cash from Financing	631.9M	-1.39B	-252.7M	-517.4M	-2.07B	-1.32B	-59.3M	779.9M	-1.46B	-36.8M
Debt Issued (Net)	956.9M	-695M	210.1M	-412.2M	-375M	0	-300M	1B	-775M	910.2M
Equity Issued (Net)	-385.5M	-700M	-490.6M	-134.5M	-1.72B	-1.15B	-1.04B	-250.1M	-395.7M	-486.5M
Dividends Paid	0	0	0	0	0	-195.2M	-254M	-243.1M	-240.7M	-240.3M
Share Repurchases	-338.1M	-700M	-450M	-134.5M	-1.72B	-1.15B	-1.04B	-250.1M	-450M	-548M
Other Financing	21.8M	5.1M	27.8M	29.3M	25.2M	23.6M	1.53B	273.1M	-45.6M	-220.2M
Net Change in Cash	-116.9M▲ 0%	110.2M▲ 194.3%	-89.3M▼ 181.0%	983.3M▲ 1201.1%	151.9M▼ 84.6%	-1.04B▼ 786.4%	106.8M▲ 110.2%	981.9M▲ 819.4%	-986.4M▼ 200.5%	611.7M▲ 0%
Free Cash Flow	1.14B▲ 0%	925.6M▼ 19.1%	1.04B▲ 12.8%	1.75B▲ 67.9%	2.65B▲ 51.1%	1.47B▼ 44.4%	874.1M▼ 40.7%	1.1B▲ 25.4%	1.21B▲ 10.0%	1.38B▲ 0%
FCF Margin %	10.96%	8.17%	9.04%	12.54%	20.17%	12.42%	7.19%	8.42%	8.64%	9.78%
FCF Growth %	27.54%	-19.09%	12.85%	67.89%	51.07%	-44.36%	-40.7%	25.37%	10.05%	20.14%
FCF per Share	11.01	9.02	10.59	17.89	27.17	16.09	9.98	12.98	14.39	14.39
FCF Conversion (FCF/Net Income)	1.15x	1.48x	1.75x	1.37x	1.31x	1.53x	3.18x	2.13x	1.87x	1.47x
Interest Paid	239.1M	296.2M	0	216.6M	194.5M	196.7M	221.5M	209.2M	0	0
Taxes Paid	348M	349.7M	0	500M	964.7M	474.9M	206.8M	215.4M	0	0

LH Key Ratios

Labcorp Holdings Inc. (LH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	TTM
Return on Equity (ROE)	20.54%	12.79%	11.3%	18.26%	24.07%	12.53%	4.64%	9.35%	10.5%	10.89%
Return on Invested Capital (ROIC)	8.45%	7.68%	7.4%	12.54%	15.21%	6.91%	3.71%	6.01%	7.81%	7.81%
Gross Margin	33.18%	28.03%	28.15%	35.43%	38.01%	31.26%	27.67%	27.86%	26.75%	27.79%
Net Margin	12.15%	7.8%	7.13%	11.13%	18.1%	10.78%	3.44%	5.73%	6.28%	6.66%
Debt / Equity	0.99x	0.87x	0.94x	0.71x	0.62x	0.62x	0.75x	0.90x	0.83x	0.83x
Interest Coverage	5.58x	6.19x	5.59x	11.70x	14.63x	7.88x	3.85x	5.61x	5.94x	6.22x
FCF Conversion	1.15x	1.48x	1.75x	1.37x	1.31x	1.53x	3.18x	2.13x	1.87x	1.47x
Revenue Growth	8.29%	8.54%	1.95%	20.98%	-6.03%	-9.68%	2.51%	6.97%	7.25%	7.34%

LH SEC Filings & Documents

Labcorp Holdings Inc. (LH) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Apr 30, 2026·SEC

Material company update

Apr 9, 2026·SEC

Material company update

Mar 31, 2026·SEC

10-K Annual Reports

FY 2026

Feb 24, 2026·SEC

FY 2025

Feb 25, 2025·SEC

10-Q Quarterly Reports

FY 2025

Oct 31, 2025·SEC

FY 2025

Aug 1, 2025·SEC

FY 2025

Apr 29, 2025·SEC

LH Frequently Asked Questions

Labcorp Holdings Inc. (LH) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Labcorp Holdings Inc. (LH) reported $14.14B in revenue for fiscal year 2025. This represents a 780% increase from $1.61B in 1996.

Labcorp Holdings Inc. (LH) grew revenue by 7.2% over the past year. This is steady growth.

Yes, Labcorp Holdings Inc. (LH) is profitable, generating $941.5M in net income for fiscal year 2025 (6.3% net margin).

Dividend & Returns

Yes, Labcorp Holdings Inc. (LH) pays a dividend with a yield of 1.12%. This makes it attractive for income-focused investors.

Labcorp Holdings Inc. (LH) has a return on equity (ROE) of 10.5%. This is reasonable for most industries.

Labcorp Holdings Inc. (LH) generated $1.38B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More LH

Labcorp Holdings Inc. (LH) financial analysis — history, returns, DCA and operating performance tools

Full LH Stock Analysis

Analyst verdict, bull/bear case, risk factors and peer comparison

→

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Labcorp Holdings Inc.(LH)Earnings, Financials & Key Ratios

LH Key Insights

✓Strengths

✗Weaknesses

LH Price & Volume

LH Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

LH Recent Earnings

LH Peer Comparison

Compare LH vs Peers

vs DGX

vs TMO

Compare Top 5

LH Income Statement

LH Balance Sheet

LH Cash Flow Statement

LH Key Ratios

LH SEC Filings & Documents

8-K Announcements

10-K Annual Reports

10-Q Quarterly Reports

LH Frequently Asked Questions

Explore More LH

Full LH Stock Analysis

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation